These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 33871202)
1. Topical imiquimod as a neo-adjuvant chemotherapy for cartilage salvage in the treatment of nodular basal cell carcinomas of the head and neck. Singh S; Rajan MB; Bhardwaj A Indian J Dermatol Venereol Leprol; 2021; 87(3):452-454. PubMed ID: 33871202 [No Abstract] [Full Text] [Related]
2. Imiquimod 5% Cream as Adjuvant Therapy in BCC Treatment Located at High-Risk Regions. Cengiz FP; Kelahmetoglu O; Emiroglu N; Onsun N J Cutan Med Surg; 2020; 24(6):640-641. PubMed ID: 32558591 [No Abstract] [Full Text] [Related]
3. Conventional and combination topical photodynamic therapy for basal cell carcinoma: systematic review and meta-analysis. Collier NJ; Haylett AK; Wong TH; Morton CA; Ibbotson SH; McKenna KE; Mallipeddi R; Moseley H; Seukeran D; Ward KA; Mohd Mustapa MF; Exton LS; Green AC; Rhodes LE Br J Dermatol; 2018 Dec; 179(6):1277-1296. PubMed ID: 29889302 [TBL] [Abstract][Full Text] [Related]
4. Pilot study of imiquimod 5% cream as adjunctive therapy to curettage and electrodesiccation for nodular basal cell carcinoma. Spencer JM Dermatol Surg; 2006 Jan; 32(1):63-9. PubMed ID: 16393600 [TBL] [Abstract][Full Text] [Related]
5. Case study: Imiquimod 5% cream in the treatment of a large nodular basal cell carcinoma. Shulstad RM Dermatol Nurs; 2009; 21(2):86-7. PubMed ID: 19507375 [TBL] [Abstract][Full Text] [Related]
6. Treatment of a large superficial basal cell carcinoma with 5% imiquimod: a case report and review of the literature. Chen TM; Rosen T; Orengo I Dermatol Surg; 2002 Apr; 28(4):344-6. PubMed ID: 11966794 [TBL] [Abstract][Full Text] [Related]
8. Cutaneous and cartilaginous lesions of the auricle. Parlette HL; Hendrix JD Facial Plast Surg; 1995 Oct; 11(4):310-8. PubMed ID: 9046619 [No Abstract] [Full Text] [Related]
9. Successful treatment of multifocal pigmented basal cell carcinomas with the application of topical 5% imiquimod cream. Plachouri KM; Balasis S; Mallioris AF; Koumoundourou D; Georgiou S Dermatol Ther; 2018 Sep; 31(5):e12685. PubMed ID: 30133929 [TBL] [Abstract][Full Text] [Related]
10. Surgery versus combined treatment with curettage and imiquimod for nodular basal cell carcinoma: One-year results of a noninferiority, randomized, controlled trial. Sinx KAE; Nelemans PJ; Kelleners-Smeets NWJ; Winnepenninckx VJL; Arits AHMM; Mosterd K J Am Acad Dermatol; 2020 Aug; 83(2):469-476. PubMed ID: 32320773 [TBL] [Abstract][Full Text] [Related]
11. Granular cell basal cell carcinoma: A rare variant. Tichy M; Sen MT Indian J Dermatol Venereol Leprol; 2015; 81(4):420-2. PubMed ID: 26087093 [No Abstract] [Full Text] [Related]
12. Sequential treatment of daylight photodynamic therapy and imiquimod 5% cream for the treatment of superficial basal cell carcinoma on sun exposed areas. Paolino G; Didona D; Scarnò M; Tallarico M; Cantoresi F; Calvieri S; Mercuri SR; Piccolo D; Bottoni U; Kyriakou A; Cantisani C Dermatol Ther; 2019 Mar; 32(2):e12788. PubMed ID: 30499211 [No Abstract] [Full Text] [Related]
13. Recurrent invasive basal cell carcinoma after radiation and imiquimod: a case report. Wagamon K; Li LJ Dermatol Surg; 2007 Jan; 33(1):117-9. PubMed ID: 17214692 [No Abstract] [Full Text] [Related]
14. Local immune modulator (imiquimod 5% cream) as adjuvant treatment after incomplete Mohs micrographic surgery for large, mixed type basal cell carcinoma: a report of 3 cases. Thissen MR; Kuijpers DI; Krekels GA J Drugs Dermatol; 2006 May; 5(5):461-4. PubMed ID: 16703785 [TBL] [Abstract][Full Text] [Related]
15. Scientific rationale: combining imiquimod and surgical treatments for basal cell carcinomas. Berman B J Drugs Dermatol; 2008 Jan; 7(1 Suppl 1):s3-6. PubMed ID: 18277456 [TBL] [Abstract][Full Text] [Related]
16. High-frequency ultrasound in auricular skin cancer surgery: a precise, in vivo tool for identification of a potential cartilage infiltration and planning the therapeutic approach. Badea A; Crisan D Int J Dermatol; 2024 Sep; 63(9):1277-1279. PubMed ID: 38600609 [No Abstract] [Full Text] [Related]
17. Topical Imiquimod as a Treatment Option for Nodular Basal Cell Carcinoma: A Systematic Review. Huang CM; Kirchhof MG J Cutan Med Surg; 2020; 24(5):495-503. PubMed ID: 32527151 [TBL] [Abstract][Full Text] [Related]
18. An open-label, pilot study examining the efficacy of curettage followed by imiquimod 5% cream for the treatment of primary nodular basal cell carcinoma. Wu JK; Oh C; Strutton G; Siller G Australas J Dermatol; 2006 Feb; 47(1):46-8. PubMed ID: 16405483 [TBL] [Abstract][Full Text] [Related]
19. Letter: Imiquimod 5% cream as adjunctive therapy for primary, solitary, nodular basal cell carcinomas before Mohs micrographic surgery: a randomized, double-blind, vehicle-controlled study. Moehrle M; Breuninger H; Schippert W; Häfner HM Dermatol Surg; 2010 Mar; 36(3):428-30. PubMed ID: 20402949 [No Abstract] [Full Text] [Related]
20. Adjuvant and Neoadjuvant Treatment of Skin Cancer. Sacco AG; Daniels GA Facial Plast Surg Clin North Am; 2019 Feb; 27(1):139-150. PubMed ID: 30420067 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]